Masimo Corporation

Symbol: MASI

NASDAQ

124.16

USD

Market price today

  • 83.1919

    P/E Ratio

  • 0.2892

    PEG Ratio

  • 6.59B

    MRK Cap

  • 0.00%

    DIV Yield

Masimo Corporation (MASI) Stock Price & Analysis

Shares Outstanding

53.09M

Gross Profit Margin

0.49%

Operating Profit Margin

0.08%

Net Profit Margin

0.04%

Return on Assets

0.03%

Return on Equity

0.06%

Return on Capital Employed

0.06%

Company general description and statistics

Sector: Healthcare
Industry: Medical - Instruments & Supplies
CEO:Mr. Joseph E. Kiani
Full-time employees:3800
City:Irvine
Address:52 Discovery
IPO:2007-08-08
CIK:0000937556

Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor hemoglobin species, including oxygen saturation, pulse rate, perfusion index, pleth variability index, and respiration rate from the pleth; noninvasively monitor hemoglobin concentration, and carboxyhemoglobin and methemoglobin; monitor arterial oxygen saturation and acoustic respiration rate; and calculates oxygen content and oxygen reserve index. It offers SedLine brain function monitoring technology to measure the brain's electrical activity by detecting EEG signals; capnography and gas monitoring products comprising external plug-in-and-measure capnography and gas analyzers, integrated modules, handheld capnograph and capnometer devices, and capnography sampling lines; O3 regional oximetry for tissue oxygen saturation measurement; and hemodynamic monitoring solutions. Its Masimo Hospital Automation platform includes Patient SafetyNet, Patient SafetyNet surveillance, Kite, UniView, Replica, UniView : 60, and MyView. It offers connectivity devices; and nasal high flow ventilation and neuromodulation solutions. It provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and non-medical/consumer products through e-commerce site, masimopersonalhealth.com. The company was incorporated in 1989 and is headquartered in Irvine, California.

General Outlook

In simple terms, Masimo Corporation has 53.086 M shares that people are buying and selling right now. When we look at how much money they make before expenses, they keep 0.486% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is 0.078%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of 0.040%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust 0.027% return, is a testament to Masimo Corporation's adeptness in optimizing resource deployment. Masimo Corporation's utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.060%. Furthermore, the proficiency of Masimo Corporation in capital utilization is underscored by a remarkable 0.063% return on capital employed.

Stock Prices

Masimo Corporation's stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $135.68, while its low point bottomed out at $132.17. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Masimo Corporation's stock market.

Liquidity Ratios

Analyzing MASI liquidity ratios reveals its financial health of the firm. The current ratio of 231.18% gauges short-term asset coverage for liabilities. The quick ratio (122.27%) assesses immediate liquidity, while the cash ratio (31.26%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio231.18%
Quick Ratio122.27%
Cash Ratio31.26%

Profitability Ratios

MASI profitability indicators offer a lens into its earnings landscape. A pretax profit margin of 4.40% underscores its earnings before tax deductions. The effective tax rate stands at 8.86%, revealing its tax efficiency. The net income per EBT, 91.02%, and the EBT per EBIT, 56.65%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of 7.76%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin4.40%
Effective Tax Rate8.86%
Net Income per EBT91.02%
EBT per EBIT56.65%
EBIT per Revenue7.76%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 2.31, it details the span from stock purchase to revenue. The 1 days it takes to settle debts showcases its creditor relations.

cards.indicatorcards.value
Days of Sales Outstanding122
Days of Inventory Outstanding182
Operating Cycle266.68
Days of Payables Outstanding73
Cash Conversion Cycle194
Receivables Turnover4.31
Payables Turnover5.00
Inventory Turnover2.01
Fixed Asset Turnover4.76
Asset Turnover0.67

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 2.63, and free cash flow per share, 1.17, depict cash generation on a per-share basis. The cash per share value, 2.97, showcases liquidity position. Lastly, the operating cash flow sales ratio, 0.07, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share2.63
Free Cash Flow per Share1.17
Cash per Share2.97
Operating Cash Flow Sales Ratio0.07
Free Cash Flow to Operating Cash Flow Ratio0.44
Cash Flow Coverage Ratio0.17
Capital Expenditure Coverage Ratio1.80
Dividend Paid and Capex Coverage Ratio1.80

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 28.45%, highlights its total liabilities relative to assets. With a debt-equity ratio of 0.62, we discern the balance between debt and equity financing. The long-term debt to capitalization, 38.13%, and total debt to capitalization, 38.13%, ratios shed light on its capital structure. An interest coverage of 3.99 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Debt Ratio28.45%
Debt Equity Ratio0.62
Long Term Debt to Capitalization38.13%
Total Debt to Capitalization38.13%
Interest Coverage3.99
Cash Flow to Debt Ratio0.17
Company Equity Multiplier2.17

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 38.79, provides a glimpse into top-line earnings distributed across each share. Net income per share, 1.54, reflects the portion of profit attributed to each share. The book value per share, 25.85, represents the net asset value distributed per share, while the tangible book value per share, -4.69, excludes intangible assets.

cards.indicatorcards.value
Revenue Per Share38.79
Net Income Per Share1.54
Book Value Per Share25.85
Tangible Book Value Per Share-4.69
Shareholders Equity Per Share25.85
Interest Debt Per Share18.46
Capex Per Share-1.66

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, 0.60%, indicates top-line expansion, while the gross profit growth, -5.22%, reveals profitability trends. EBIT growth, -21.76%, and operating income growth, -21.76%, offer insights into operational profitability progression. The net income growth, -43.21%, showcases bottom-line expansion, and the EPS growth, -42.54%, measures the growth in earnings per share.

cards.indicatorcards.value
Revenue Growth0.60%
Gross Profit Growth-5.22%
EBIT Growth-21.76%
Operating Income Growth-21.76%
Net Income Growth-43.21%
EPS Growth-42.54%
EPS Diluted Growth-41.92%
Weighted Average Shares Growth-1.49%
Weighted Average Shares Diluted Growth-1.99%
Operating Cash Flow Growth218.98%
Free Cash Flow Growth123.88%
10-Year Revenue Growth per Share301.83%
5-Year Revenue Growth per Share153.26%
3-Year Revenue Growth per Share85.51%
10-Year Operating CF Growth per Share86.01%
5-Year Operating CF Growth per Share-58.30%
3-Year Operating CF Growth per Share-53.79%
10-Year Net Income Growth per Share49.89%
5-Year Net Income Growth per Share-55.31%
3-Year Net Income Growth per Share-64.86%
10-Year Shareholders Equity Growth per Share348.85%
5-Year Shareholders Equity Growth per Share49.48%
3-Year Shareholders Equity Growth per Share0.44%
Receivables Growth-5.58%
Inventory Growth8.78%
Asset Growth-5.27%
Book Value per Share Growth3.48%
Debt Growth-0.55%
R&D Expense Growth-8.46%
SGA Expenses Growth1.00%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 6,992,688,000, captures the company's total value, considering both debt and equity. Income quality, 1.15, assesses the reliability of reported earnings. The sales, general, and administrative to revenue ratio, 0.29, gauges operational efficiency, while the research and development to revenue, 8.55%, highlights investment in innovation. The ratio of intangibles to total assets, 53.01%, indicates the value of non-physical assets, and capex to operating cash flow, -93.20%, measures reinvestment capability.

cards.indicatorcards.value
Enterprise Value6,992,688,000
Income Quality1.15
Sales General and Administrative to Revenue0.29
Research and Development to Revenue8.55%
Intangibles to Total Assets53.01%
Capex to Operating Cash Flow-93.20%
Capex to Revenue-4.28%
Capex to Depreciation-89.22%
Stock-Based Compensation to Revenue0.34%
Graham Number29.96
Return on Tangible Assets5.70%
Graham Net Net-17.47
Working Capital668,100,000
Tangible Asset Value-247,500,000
Net Current Asset Value-444,800,000
Invested Capital1
Average Receivables433,450,000
Average Payables264,150,000
Average Inventory523,000,000
Days Sales Outstanding75
Days Payables Outstanding88
Days of Inventory On Hand190
ROIC6.64%
ROE0.06%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 4.82, and the price to book ratio, 4.82, reflect the market's valuation relative to the company's book value. The price to sales ratio, 3.32, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, 106.31, and price to operating cash flows, 47.17, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio4.82
Price to Book Ratio4.82
Price to Sales Ratio3.32
Price Cash Flow Ratio47.17
Price Earnings to Growth Ratio0.29
Enterprise Value Multiple24.57
Price Fair Value4.82
Price to Operating Cash Flow Ratio47.17
Price to Free Cash Flows Ratio106.31
Price to Tangible Book Ratio4.53
Enterprise Value to Sales3.41
Enterprise Value Over EBITDA26.63
EV to Operating Cash Flow74.31
Earnings Yield1.32%
Free Cash Flow Yield0.10%
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of Masimo Corporation (MASI) on the NASDAQ in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is 83.192 in 2024.

What is the ticker symbol of Masimo Corporation stock?

The ticker symbol of Masimo Corporation stock is MASI.

What is company IPO date?

IPO date of Masimo Corporation is 2007-08-08.

What is company current share price?

Current share price is 124.160 USD.

What is stock market cap today?

The market cap of stock today is 6591108096.000.

What is PEG ratio in 2024?

The current 0.289 is 0.289 in 2024.

What is the number of employees in 2024?

In 2024 the company has 3800.